BETAPROX Trademark

Trademark Overview

On Wednesday, February 17, 2021, a trademark application was filed for BETAPROX with the United States Patent and Trademark Office. The USPTO has given the BETAPROX trademark a serial number of 90531512. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Saturday, May 4, 2024. This trademark is owned by Nutrartis S.A.. The BETAPROX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of prostate disease
betaprox

General Information

Serial Number90531512
Word MarkBETAPROX
Filing DateWednesday, February 17, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateSaturday, May 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of prostate disease
Pseudo MarkBETA PROX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNutrartis S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSantiago 8700548
CL
Party NameNutrartis S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSantiago 8700548
CL

Trademark Events

Event DateEvent Description
Monday, September 13, 2021ASSIGNED TO EXAMINER
Saturday, February 20, 2021NEW APPLICATION ENTERED
Wednesday, May 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 11, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 11, 2022SOU EXTENSION 1 FILED
Friday, March 11, 2022SOU EXTENSION 1 GRANTED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, October 30, 2022SOU EXTENSION 2 GRANTED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, October 30, 2022SOU TEAS EXTENSION RECEIVED
Sunday, October 30, 2022SOU EXTENSION 2 FILED
Friday, May 12, 2023SOU EXTENSION 3 FILED
Friday, May 12, 2023SOU EXTENSION 3 GRANTED
Tuesday, May 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 12, 2023SOU TEAS EXTENSION RECEIVED
Saturday, May 4, 2024SOU EXTENSION 5 GRANTED
Saturday, May 4, 2024SOU EXTENSION 5 FILED
Saturday, May 4, 2024SOU TEAS EXTENSION RECEIVED
Friday, November 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 22, 2023SOU EXTENSION 4 FILED
Wednesday, November 22, 2023SOU EXTENSION 4 GRANTED

Related Keywords

betaprox disease prostate prevention preparations pharmaceutical